FNY Investment Advisers’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-700
Closed -$17K 720
2019
Q4
$17K Sell
700
-340
-33% -$7.89K 0.01% 594
2019
Q3
$22K Hold
1,040
0.01% 493
2019
Q2
$33K Buy
1,040
+440
+73% +$13.8K 0.01% 419
2019
Q1
$19K Buy
600
+450
+300% +$14K 0.01% 406
2018
Q4
$4K Buy
+150
New +$5.66K ﹤0.01% 548

Other funds holding PAHC

FNY Investment Advisers's PAHC Position: Q1 2020 in Review

FNY Investment Advisers sold out of Phibro Animal Health (PAHC) in Q1 2020, closing a stake of 700 shares — an estimated $17K sold.

FNY Investment Advisers first reported a position in PAHC in Q4 2018 and held it in 5 quarters. The position peaked at $33K in Q2 2019. 155 funds tracked by Wall St. Rank hold PAHC as of Q1 2020.

  • FNY Investment Advisers reported no remaining Phibro Animal Health position as of Q1 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 700 Phibro Animal Health shares in Q1 2020, an estimated $17K.
  • FNY Investment Advisers first reported a position in Phibro Animal Health in Q4 2018 and held it in 5 quarters.
  • FNY Investment Advisers's Phibro Animal Health position peaked at $33K in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2020.

Based on FNY Investment Advisers's 13F filing for Q1 2020, filed 9 Apr 2020.